Biggest News Aggregation in the World
📰 High Throughput Screening News

Page 11 - High Throughput Screening News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from High Throughput Screening. Real-time updates on events, politics, business and more.

Penn researchers discover drug that blocks multiple SARS-CoV-2 variants in mice

 E-Mail The drug diABZI -- which activates the bodys innate immune response -- was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Science Immunology, suggest that diABZI could also treat other respiratory coronaviruses. "Few drugs have been identified as game-changers in blocking SARS-CoV-2 infection. This paper is th...
South Africa South African Laboratory Medicine Drug Administration University Of Pennsylvania Perelman School Of Medicine

The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company's Personalized Medicine Drug Discovery Technology

The European Patent Office Grants Cannabics Pharmaceuticals Patent for Companys Personalized Medicine Drug Discovery Technology USA - English Share this article Share this article TEL AVIV, Israel and BETHESDA, Md., May 25, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the companys patent titled: "System and Method for High Throughput Screening of Cancer Cells" has bee...
South Africa Eyal Ballan Gabriel Yariv Facebook Cannabicspharmaceuticals Instagram Cannabics European Patent Office

Worldwide Liquid Handling System Industry to 2026 - Increasing Research Activities in Genomics and Proteomics Presents Opportunities

Share this article Share this article ResearchAndMarkets.coms offering. The Global Liquid Handling System Market is estimated to be USD 3.53 Bn in 2021 and is expected to reach USD 4.98 Bn by 2026, growing at a CAGR of 7.1%. Market Dynamics Major factors that drive the market growth are increasing expenditure in research & development activities, growing technological advancements, the need for new drug development, and the growing demand for high-output screening. All these help in driving th...
Nordrhein Westfalen United States United Kingdom South Africa United Arab Emirates Saudi Arabia

Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies

Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies Measuring the presence and performance of neutralizing antibodies is crucial in the fight against the coronavirus disease 2019 (COVID-19) pandemic. This allows us to glimpse how effective vaccines and antibody therapies are in conferring protective immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Researchers in Germany and the U.S. described 11 unique nanobodies (Nbs) ...
Bio Shutterstock Angela Betsaidab Laguipo Eberhard Karls University Angela Betsaida Embo Reports Huen Structure Bio

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapys 24th Annual Meeting News provided by Share this article Share this article ROCKVILLE, Md., April 27, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapys 24 th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. Presentations and posters will be available at https://...
United States David Rosen April Giles Kirk Elliot Shaojie Weng Roberto Giugliani

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Researchers identify SARS-CoV-2 antiviral compounds using protein assay

During the process of SARS-CoV-2 infection, once the virus penetrates the host cell, two open reading frames, ORF1a and ORF1ab, are translated. ORF1ab is responsible for the production of 16 nonstructural proteins (nsp). Several viral proteases such as 3CLpro and PLpro (papain-like protease) produce 1-16 nsps. A new study has been published in bioRxiv* preprint server, which deals with identifying drugs that are effective as PLpro inhibitors.
Priyom Bose World Health Organization Drug Administration Francis Crick Institute Small Molecule Inhibitors Image Credit

Worldwide Liquid Handling System Industry to 2025 - Increasing Research Activities in Genomics and Proteomics Presents Opportunities

Share this article Share this article ResearchAndMarkets.coms offering. The Global Liquid Handling System Market is estimated to be USD 3.3 Bn in 2020 and is expected to reach USD 4.65 Bn by 2025, growing at a CAGR of 7.1%. Market Dynamics Major factors that drive the market growth are increasing expenditure in research & development activities, growing technological advancements, the need for new drug development, and the growing demand for high-output screening. All these help in driving the...
Nordrhein Westfalen United States United Kingdom South Africa United Arab Emirates Saudi Arabia

Researchers discover SARS-CoV-2 inhibitors

 E-Mail IMAGE: with one of the newly developed inhibitors in the active centre. The individual domains of the protein are shown in different colours, the inhibitor in pink. view more  Credit: © V. Namasivayam/Pharmazeutisches Institut/Uni Bonn A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus. The drug candidates are able to switch off the the key enzyme of the virus, ...
Nordrhein Westfalen Vigneshwaran Namasivayam Katharina Sylvester Dominik Thimm Ghazl Al Hamwi Christin Vielmuth

Pharmacists discover active substances that block SARS-CoV-2 replication

A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus. The drug candidates are able to switch off the the key enzyme of the virus, the so-called main protease.
Nordrhein Westfalen Angewandte Chemie Emily Henderson University Of Bonn Transdisciplinary Research Area Life Institute Of The University Bonn

Biological activity-based modeling offers a new approach for drug discovery

Biological activity-based modeling offers a new approach for drug discovery Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases. This action-based focus -- called biological activity-based modeling (BABM) -- forms the core of a new approach developed by the National Center for Advancing Translational Sciences (NCATS) researchers and others. NCATS is part o...
Wei Zheng Ruili Huang Emily Henderson National Center National Institutes Of Health Translational Sciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science